Biologics

5 key vendors in the global stem cell therapy market

The global stem cell therapy market is projected to grow at a compound annual growth rate of 36.52 percent between 2017 and 2021, according to an analysis by Wise Guy Reports.

By: Staff

Friday, March 16th, 2018

The market is propelled forward by an increase in federal funding for stem cell therapy. Here are five key vendors.

1. Holostem Advanced Therapies

2. JCR Pharmaceuticals

3. Organogenesis

4. Osiris Therapeutics

5. Vericel

More articles on biologics:

Cerapedics receives FDA IDE approval for study of P-15L Bone Graft in TLIF surgery: 4 things to know

Drs. Kevin Pauza, Gregory Lutz launch study into non-invasive degenerated disc treatment: 5 highlights

4 things to know about mensenchymal stromal cells in spine

Next Up in Biologics

4 orthobiologics updates

Here are four updates in spine and orthopedic biologics since Nov. 6. 1. Xtant Medical’s CollagenX wound healing product is…

By: Carly Behm
2 days ago
Cerapedics' PearlMatrix bone graft superior to local autograft: Study

A 24-month study of Cerapedics’ PearlMatrix P-15 peptide enhanced bone graft found it had better time-to-fusion and clinical success than…

By: Carly Behm
Wednesday, December 17th, 2025
Xtant Medical launches new bone graft

Xtant Medical released its nanOss Strata synthetic bone graft in a commercial launch, according to a Dec. 11 news release.…

By: Carly Behm
Thursday, December 11th, 2025

Comments are closed.

From Foundation to Frontier: Radiology Leaders Discuss Scaling AI in Imaging

Next Up in Biologics

4 orthobiologics updates

Cerapedics' PearlMatrix bone graft superior to local autograft: Study

Xtant Medical launches new bone graft

Join the spine leaders & surgeons who start their day with Becker's